Denali Therapeutics Inc. (DNLI) operating margin

Operating margin · fiscal 2023
-59.5%

Denali Therapeutics Inc. (DNLI) had an operating margin of -59.5% in fiscal 2023 (the year ended December 31, 2023). That is 254.6 percentage points higher than the -314.2% of fiscal 2022. Figures as of 17 Nov 2026, 20:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2023
-59.5%
Change on fiscal 2022
+254.6 pts
Highest on record
18.7%fiscal 2020
Lowest on record
-810.0%fiscal 2019
Fiscal years on record
62018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Denali Therapeutics Inc. operating margin, in more detail

Across the 6 fiscal years on record (2018–2023), the highest was 18.7% in fiscal 2020 and the lowest -810.0% in fiscal 2019. The fiscal 2023 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -314.2%.

Net margin was -43.9% in fiscal 2023.

History · 6 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Denali Therapeutics Inc. operating margin, year by year

Denali Therapeutics Inc. (DNLI) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2023-59.5% 254.6 pts up-43.9%
2022-314.2% 293.7 pts up-300.6%
2021-607.8% 626.5 pts down-597.2%
202018.7% 828.7 pts up21.2%
2019-810.0% 774.1 pts down-750.8%
2018-35.9%—-28.1%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on DNLI

Denali Therapeutics Inc., figure by figure

Denali Therapeutics Inc. (DNLI) overview: price, valuation and scorecard

Denali Therapeutics Inc. operating margin: questions and answers

What is Denali Therapeutics Inc.'s operating margin?

Denali Therapeutics Inc. (DNLI) had an operating margin of -59.5% in fiscal 2023 (the year ended December 31, 2023). That is 254.6 percentage points higher than the -314.2% of fiscal 2022.

Is Denali Therapeutics Inc.'s operating margin high or low compared with its own history?

The fiscal 2023 figure is higher than in 60% of the 5 earlier fiscal years on record, whose median is -314.2%.

What are the highest and lowest operating margin figures on record for Denali Therapeutics Inc.?

Across the 6 fiscal years on record (2018–2023), the highest was 18.7% in fiscal 2020 and the lowest -810.0% in fiscal 2019.

What are Denali Therapeutics Inc.'s gross and net margins?

Net margin was -43.9% in fiscal 2023.

How is Denali Therapeutics Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Denali Therapeutics Inc. (DNLI) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/DNLI/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.